Authored By: Sarah
11 Jul 2024

 Effervescent Tablet Market Size to grow by USD 4.80 billion between 2024-2028

According to a research report “ Effervescent Tablet Market” by Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy) Type (Prescription, Over the counter) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 4.80 billion, at a CAGR of  8.36% during the forecast period. The effervescent tablet market is experiencing significant growth due to the increasing consumer awareness and preference for health-enhancing products, particularly nutritional supplements. This trend is expected to continue during the forecast period. Moreover, the global population aging (65 years and above) is fueling the demand for anti-aging solutions in the form of professional skincare products. Key anti-aging concerns include wrinkles, dark spots, dark circles, hyperpigmentation, and uneven skin tones. In response, manufacturers of anti-aging products are developing effervescent tablets containing natural supplements like vitamin C, which stimulates collagen production and is essential for youthful skin. Other natural antioxidants, such as niacinamide, resveratrol, vitamin E, retinol (Vitamin A), Coenzyme Q10, and polyphenols, are also commonly used in personal care products to combat the signs of aging.

Browse market data tables, figures, and in-depth TOC on “Effervescent Tablet Market” by Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy) Type (Prescription, Over the counter) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Distribution Channel, the Hospital pharmacy segment is projected to dominate the market size in 2024

In the pharmaceutical industry, a prescription drug is a medication that requires a medical practitioner's written authorization for use by a patient. Such drugs, including blood pressure medications, cancer treatments, and potent painkillers, are classified as prescription due to their potential risks, complex administration methods, and safety concerns. The escalating burden of chronic diseases, the growing number of physician consultations, and increasing healthcare expenditures by individuals are expected to fuel the expansion of the prescription segment within the global effervescent tablet market throughout the forecast period.

By Type, Prescription  segment is expected to hold the largest market size for the year 2024

The global effervescent tablet market is poised for significant growth due to the increasing prevalence of diseases such as flu and gastrointestinal disorders, leading to a rise in hospitalizations. With an increasing number of public and private specialty hospitals and clinics, the hospital pharmacy segment will experience substantial growth. Equipped with advanced medical infrastructure, these institutions procure high-quality medical products, including effervescent tablets, in bulk. Moreover, the rise in patient admissions with symptoms like headache, nausea, vomiting, photophobia, and phonophobia will further fuel the demand for effervescent tablets, thereby propelling the market growth during the forecast period.

North America is forecasted to hold the largest market size by region in 2024

The effervescent tablet market in North America is experiencing significant growth due to the increasing consumer preference for health-conscious products, including dietary supplements, probiotics, vitamins, and minerals. This trend is driven by the rising awareness of maintaining a healthy lifestyle and preventing lifestyle diseases. Factors such as the increasing disposable income of consumers, continuous product innovations, and the expanding retail space in the region are further boosting market growth. However, regulatory challenges posed by the proliferation of counterfeit products, particularly through online sales channels, pose a significant hindrance to market expansion. Despite this, the market is expected to continue its upward trajectory, fueled by the relentless pursuit of wellness and the unyielding demand for convenient and effective health solutions.

The Effervescent Tablet Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Alturix Ltd.
  • Bayer AG
  • Bliss GVS Pharma Ltd.
  • Bristol Myers Squibb Co.
  • CHIESI Farmaceutici SpA
  • GlaxoSmithKline Plc
  • Herbalife International of America Inc.
  • HERMES PHARMA GmbH
  • Natur Produkt Zdrovit Sp Z O O
  • Nestle SA
  • Novartis AG
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • SciTech Specialities Pvt Ltd.
  • Strava Healthcare Pvt. Ltd.
  • S. G. Biopharm Pvt. Ltd.
  • Swisse Wellness Pty Ltd.
  • Vitabiotics Ltd.
  • Vovantis Laboratories
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The effervescent tablet market caters to various demographic groups, particularly those dealing with health issues related to vitamins and minerals deficiencies. Producers of effervescent tablets have identified significant market opportunities, as these tablets offer advantages over conventional solid dosage forms like capsules and tablets. The effervescent reaction, which involves the release of carbon dioxide upon contact with water, provides faster dissolution and improved bioavailability. However, the manufacturing process of effervescent tablets involves additional processing steps, such as tablet disintegration, mixing, granulation, and tablet compression. These steps increase production costs and require specialized equipment, raw ingredients, personnel, and regulatory compliance. According to a study published in the 'Pharmaceuticals' journal, the high production costs and additional packaging needs are market restraints for the effervescent tablet industry. Nevertheless, the growing trend towards precise ingredient control and the overall health benefits associated with vitamins and minerals make effervescent tablets an attractive option for consumers. Despite the challenges, the market for effervescent tablets, including those for dietary supplements, is expected to grow due to their unique benefits and the increasing demand for convenient and effective health solutions.

Market Research Overview

The Effervescent Tablet Market encompasses a wide range of products, including dental irrigators, mouth rinses for dental health, antacids, analgesics, and various other pharmaceutical and healthcare products. These tablets are available at various retail outlets such as supermarkets, hypermarkets, e-commerce platforms, drug stores, retail pharmacies, specialty clinics, hospitals, and pharmacies. End-user segments include dental products for oral cleanliness, enzymes, fluoride, antibacterial agents, and antioxidants for dental health. Effervescent tablets are also used in pain management for respiratory diseases and gastric disorders. Diuretics, antacids, and analgesics are major contributors to the market. Effervescent tablets come in various forms, such as coated, flavored, and fizzy solutions, providing immediate relief and a pleasurable experience for users. The manufacturing process involves tablet presses, wet or dry granulation, and precise ingredient control to ensure homogeneous distribution and consistent tablet shape. The market for effervescent tablets is driven by the growing demand for Over-the-counter (OTC) medications, nutrients, minerals, vitamins, and prescription medications for chronic disorders such as cardiovascular disease, diabetes, and hypertension. The global effervescent tablet market is expected to grow due to the wider customer base, regulatory compliance, and marketing points such as health benefits, electrolytes, antioxidants, amino acids, and herbal extracts. However, high production costs, additional packaging needs, and specialized equipment are major market restraints. The market also offers opportunities for producers to cater to demographic groups with specific health issues, such as older persons, children, and those with cognitive function or bone health concerns. According to the journal 'Pharmaceuticals', the manufacturing process for effervescent tablets involves tablet compression, mixing, granulation, and packing. Regulatory compliance and quality control personnel and equipment are essential for ensuring the safety and efficacy of these products. The use of herbal alternatives, citrusy or fruity flavors, and functional components such as cognitive function and bone health additives are marketing points for producers. (Word count: 120)

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio